Since its founding in 1997, Genedata has been supporting the transformation of biopharma R&D. Today, the Genedata Biopharma Platform digitalizes biopharmaceutical R&D processes, streamlining the entire R&D workflow to increase throughput and improve data quality.
Relied on by global biopharma giants and cutting-edge biotechs, the Genedata Biopharma Platform helps organizations to significantly reduce costs, accelerate workflows and improve overall productivity.
The Genedata Biopharma Platform enables automation of complex R&D processes for any therapeutic format and modality.
Unlike traditional electronic lab notebooks (ELNs) or laboratory information management systems (LIMS), the Genedata Biopharma Platform is a next-generation platform that drives process efficiency and innovation by integrating R&D workflows, automating R&D operations, eliminating bottlenecks, and fostering collaboration.
With built-in business logic and an open architecture, it simplifies daily work, leverages results on a corporate scale, and empowers the establishment of novel R&D technologies and workflows.
New robotic systems and laboratory automation have dramatically increased the amount of experimental data for capture, processing, and analysis. Only a truly scalable platform can manage the exponentially growing volume of data, which fuels next-generation artificial intelligence (AI) and machine learning (ML) technologies.
AI approaches such as Deep Learning require systematic access to structured data to extract patterns to guide future R&D projects. Unstructured data repositories, even when centralized, make it impossible to make sense out of the data. Only a fully integrated data infrastructure can transform R&D operations.
AI is here. Are you ready?
Transformative. Our Services.
Genedata offers a variety of consulting and professional services to complement our Genedata Biopharma Platform. These services facilitate optimal setup and usage of the platform, easily adopting best practices—on premises or as Software as a Service (SaaS).
One of the reasons we chose Genedata was the platform’s process coverage. We required that the full diversity of Pfizer’s large-molecule processes and technologies be supported by one integrated system.
Sergio Rotstein, Ph.D.
Director of Research Business Technology
During our initial deployment, we recorded quantifiable increases in productivity. The number of results posted to our data warehouse more than doubled, indicating that we could capture results from many more experiments, while the cost of running day-to-day operations decreased.
Vice President, Discovery Biology, Discovery Sciences
We are excited to implement the Genedata Biopharma Platform as a central integrated data backbone to streamline the capture, integration, democratization, and analysis of increasingly complex and diverse data types.
Hisham Hamadeh, Ph.D.
Vice President, Global Head of Data Sciences
The Biologics Data Platform supports our scientists in a complex, multi-site environment by providing all the necessary information and tools to streamline the biologics lead generation and optimization process.
Heiner Apeler, Ph.D.
Director of Molecular and Antibody Biology
Bayer Schering Pharma
Genedata enables us to integrate a wide variety of complex data generated by novel experimental workflows so we can gain a holistic molecular understanding of production cells with the goal of developing high performing bioproduction processes.
Ruth Wagner, Ph.D.
Group Manager of Cell Line Engineering
We need to enhance our capacity to analyze large amounts of high-dimensional ‘omic data emerging from our rapidly growing number of translational and clinical research projects. We chose Genedata because it is the end-to-end enterprise software able to harmonize our dispersed data analysis pipelines.
Department Manager of Clinical Pharmacology
We aimed to extend automation and further enhance the efficiency of our cell line, upstream and bioanalytical development operations, and quickly realized that Genedata addresses many of our requirements off-the-shelf, eliminating the need for expensive customization.
Hugo de Wit
Sartorius Stedim Cellca and Sartorius Stedim BioOutsource
To optimally handle the complex data, we need a centralized genome knowledge management and analysis solution that addresses the interdisciplinary challenges in next-generation biotechnology innovations. Genedata was our obvious choice.
Harald Bradl, Ph.D.
Director, Cell Culture and Process Sciences
Genedata provides comprehensive biologics data management functionality and the flexibility needed to support our proprietary antibody discovery processes and technology portfolio. And, it provides this functionality out-of-the-box, which saves valuable research time and money.
Markus Enzelberger, Ph.D.
Senior Vice President and Head of Discovery, Alliances and Technologies
We especially appreciated the high level of expertise and support provided by Genedata, which enabled us to optimize every stage of our analytical processes—while incorporating industry best practices—and quickly generate high-quality results.
Juliet Padden Ph.D.
Laboratory Head Analytical Development
Bayer Pharmaceuticals, Wuppertal, Germany